<div id="readability-page-1"><div><p>Kaneka Corporation has begun sales of its i-ED COIL, a brain aneurysm embolization coil in Europe as of October. The product obtained EC certification under an EU Medical Device Regulation in July and will be distributed primarily in Europe through Kaneka Medical Europe N.V. The i-ED COIL provides world-class flexibility, enabled by its specialized wire thickness and structural features. This flexibility enables coils to be packed more densely within aneurysms than conventional products and allows treatment of aneurysms with irregular shapes.</p><p>Its role in reducing the risk of aneurysm rupture is highly regarded by physicians, and since its launch in the Japanese market in 2019, sales have continued to grow steadily. Kaneka is expanding its business in a wide range of fields, which include devices for the treatment of cardiac, peripheral vascular, and cerebrovascular diseases, as well as medical devices used in the treatment of gastrointestinal tract diseases. Looking ahead, company aim to strengthen the global reach of products such as i-ED COIL and achieve sales of JPY 300 billion by 2030 in the Health Care Solution Unit including these medical businesses.</p></div></div>

4118

<p>金华株式会社已于 10 月在欧洲推出其 i-ED COIL 脑动脉瘤栓塞线圈，此前于 7 月获得了欧洲认证。该产品在治疗不规则形状的动脉瘤时提供了更好的灵活性，并预计能降低破裂风险。自 2019 年在日本推出以来，销售稳步增长。金华计划扩大其医疗器械业务，并在 2030 年前实现健康护理解决方案部门 3000 亿日元的销售目标</p>

金化公司通过在欧洲推出 i-ED COIL 扩大其全球影响力